Hyaluronic Acid Products for Osteoarthritis of the Knee

Williams J Badley E . Epidemiology of arthritis and osteoporosis. In: Arthritis and related conditions. Toronto: Institute for Clinical Evaluative Sciences; 1998. Available: www.ices.on.ca/file/Arth-chp1-.pdf (accessed August 27, 2006).

Ontario Ministry of Health and Long-Term Care. Intra-articular viscosupplementation with Hylan G-F 20 to treat osteoarthritis of the knee. Health Technology Literature Review. June 2005. Available: www.health.gov.on.ca/english/providers/program/mas/tech/reviews/pdf/rev_hylan_061705.pdf (accessed August 8, 2006).

Jordan KM Arden NK Doherty M EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62(12):1145–55.

DiPiro JT Talbert RL Yee GC eds. Pharmacotherapy: a pathophysiologic approach. 6th ed. New York: McGraw-Hill; 2005.

Lo GH LaValley M McAlindon T Felson DT . Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003;290(23):3115–21.

Dagenais S . Intra-articular hyaluronic acid (viscosupplementation) for knee osteoarthritis. Issues Emerg Health Technol 2006;94:1–4.

Bellamy N Campbell J Robinson V Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006 Apr 19;(2):CD005321.

Wang CT Lin J Chang CJ Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004;86-A(3):538–45.

Aggarwal A Sempowski IP . Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature. Can Fam Physician 2004;50:249–56.

Arrich J Piribauer F Mad P Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005;172(8):1039–43.

Gossec L Dougados M . Do intra-articular therapies work and who will benefit most? Best Pract Res Clin Rheumatol 2006;20(1):131–44.

Nesic M Harrison B Haziza P . Hylan G-F 20 (Synvisc): reported incidents of joint inflammation and pain. Canadian Adverse Reaction Newsletter 2005;15(2):1. Available: www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/medeff/carn-bcei_v15n2_e.pdf (accessed December 4, 2006).

Q-Med AB . Durolane instructions for use. Available: pns.q-med.phosworks.net/graphics/1595.pdf (accessed November 24, 2006).

Hyalgan . Hyalgan physician information. Available: www.hyalgan.ca/base_info.html (accessed November 20, 2006).

Synvisc product information sheet. November 15, 2004. Available: www.synvisc.com/ussyn_synvisc_pi.pdf (accessed November 24, 2006).

Health Canada. Medical Devices Licence Listing [cited November 24, 2006]. Available from: mdall.ca/ (accessed March 2, 2007).

Duthie L . Medical Devices Bureau, Health Canada. Ottawa, ON. Personal communication; November 28, 2006.

Hinberg I . Medical Devices Bureau, Health Canada. Ottawa, ON. Personal communication; November 28, 2006.

Q-Med AB . NASHA — the monograph. Uppsala, Sweden; 2001.

Biomet Europe. Fermathron. Available: www.biomet.co.uk/index.php?id=7032 (accessed August 23, 2006).

Stellar Pharmaceuticals Inc. NeoVisc product information sheet. London, ON; (undated).

Rivex Pharma Inc. OrthoVisc comprehensive product monograph. New York: Anaka Therapeutics, Inc.; 2003.

Ostenil . Ostenil product monograph. Available: www.ostenil.ca/ostenilR/monographie-de-produit/ (accessed July 31, 2006).

Ferland D . Garvinci International Inc. St-Eustache, QC. Personal communication; August 28, 2006.

Supartz . Supartz package insert. Available: www.supartz.com/pdfs/PackageInsert.pdf (accessed July 31, 2006).

LePage J . Smith & Nephew, Inc. St-Laurent, QC. Personal communication; November 24, 2006.

Bioniche Pharma (Canada) Ltd. Suplasyn product information sheet. Belleville, ON. February 26, 2004.